Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A ROS-Responsive Photothermal Hydrogel for Tumor Microenvironment Reprogramming and STING-Mediated Immune Engagement.

Created on 17 Aug 2026

Authors

Jie Sun, Yunyun Wu, Sheng Zhao, Jing Zhu, Yang Yang, Hongrui Zhu, Daqing Xia, Jixi Zhang

Published in

ACS applied materials & interfaces. Aug 17, 2026. Epub Aug 17, 2026.

Abstract

Photothermal therapy can induce local tumor cell death and trigger antitumor immune responses. However, its efficacy is often limited by insufficient lymph node immune priming and by sustained ROS generated from thermal stress, which suppress immune cell function. An oxidative-stress-responsive injectable hydrogel-nanoparticle composite (TP@PPM) was constructed by embedding MSA-2-loaded PEGylated polydopamine nanoparticles (PPM) into a TSPBA-PVA hydrogel. Upon near-infrared (NIR) irradiation, PPM mediated photothermal cytotoxicity, induced tumor-cell thermal stress and mitochondrial dysfunction, and generated reactive oxygen species (ROS), triggering immunogenic cell death. The relatively stable and diffusible H2O2 generated within the tumor microenvironment can enter the tumor interstitium and oxidize boronate ester crosslinks in the hydrogel, thereby promoting hydrogel degradation and enabling controlled PPM release. Then, the PPM accumulated in tumor-draining lymph nodes within 6 h and delivered MSA-2 to dendritic cells and activated the STING pathway. In vitro, TP@PPM attenuated MDSC-associated ROS accumulation and restored T cell proliferation to 44.8% in an MDSC-T cell coculture system. In vivo, TP@PPM combined with NIR irradiation promoted the infiltration of CD8+/CD4+ T cell and reduced pulmonary metastasis of the tumor. This hydrogel-nanoparticle composite platform helps overcome photothermal therapy-induced immune suppression, reduce oxidative stress in the TME, and inhibit tumor metastasis, offering a promising strategy for enhancing cancer immunotherapy.

PMID:
42604743
Bibliographic data and abstract were imported from PubMed on 17 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement